Baxter 70% Dextrose Injection recalled for stainless steel particles
Baxter dextrose injection recalled for stainless steel particles
Baxter is recalling one lot of 70% Dextrose Injection used in hospitals and care facilities because stainless steel particles were found in the solution. If given intravenously, these particles could cause blood clots, block blood vessels, or damage organs. No patient injuries have been reported so far.
- If you work at a healthcare facility, stop using lot Y495066 (expiration 31-Jul-2027) immediately.
- Return all affected units to Baxter according to your facility's process.
- If a home care facility prepared nutrition solutions with this lot, contact your patients to stop using those solutions.
- Call Baxter at 888-229-0001 (Mon–Fri, 7 am–6 pm CT) if you have questions.
- Contact your doctor or call the FDA at 1-800-FDA-0178 if you experienced any problems after receiving this product.
Product photos
FOR IMMEDIATE RELEASE – AUG. 25, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling one lot of 70% Dextrose Injection due to the potential presence of particulate matter identified as stainless steel particles in the solution.
Official notice
https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/baxter-issues-voluntary-nationwide-recall-one-lot-70-dextrose-injection-due-potential-presenceMore Baxter recalls
Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief